{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:05:03Z","timestamp":1770822303585,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1053\/j.seminhematol.2004.02.008","type":"journal-article","created":{"date-parts":[[2004,6,9]],"date-time":"2004-06-09T13:00:54Z","timestamp":1086786054000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"S3","title":["Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders"],"prefix":"10.1053","volume":"41","author":[{"given":"Craig M","family":"Kessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.02.008_BIB1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/1040-8428(94)00164-O","article-title":"Bleeding and thrombosis in myeloproliferative disorders","volume":"20","author":"Landolfi","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-996114","article-title":"Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders","volume":"23","author":"Wehmeier","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2007-996125","article-title":"Microvascular disturbances, thrombosis, and bleeding in thrombocythemia","volume":"23","author":"Ravandi-Kashani","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajh.1145","article-title":"Relationships between thrombohemorrhagic complications and platelet function in patients with essential thrombocythaemia","volume":"68","author":"Raszeja-Specht","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI111840","article-title":"Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia","volume":"75","author":"Raskind","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0038-1657135","article-title":"Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders","volume":"47","author":"Pareti","year":"1982","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2141.1985.tb07419.x","article-title":"Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis","volume":"60","author":"Clezardin","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB8","first-page":"954","article-title":"Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease","volume":"111","author":"Kaplan","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2141.1989.tb07755.x","article-title":"Platelet membrane abnormalities in myeloproliferative disorders","volume":"73","author":"Mazzucato","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0038-1646416","article-title":"125I-fibrinogen binding to platelets in myeloproliferative disease","volume":"66","author":"Mistry","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1096-8652(199601)51:1<79::AID-AJH13>3.0.CO;2-6","article-title":"Platelet activation and thrombosis","volume":"51","author":"Nurden","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ajh.10254","article-title":"Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders","volume":"72","author":"Amitrano","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB13","first-page":"149","article-title":"Prevalence of specific thrombotic accidents in patients with thrombocytosis","volume":"25","author":"Randi","year":"1993","journal-title":"Haematologia"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/107602960200800409","article-title":"Thrombocytosis and recurrent hepatic outflow obstruction (Budd-Chiari syndrome) after successful thrombolysis","volume":"8","author":"Randi","year":"2002","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB15","first-page":"1180","article-title":"Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia","volume":"87","author":"Randi","year":"2002","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0037-1963(01)90137-4","article-title":"Current management in polycythemia vera","volume":"38","author":"Gilbert","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bmj.287.6397.935","article-title":"Lacunar infarcts in polycythaemia with raised packed cell volumes","volume":"287","author":"Pearce","year":"1983","journal-title":"Br Med J"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(96)00051-2","article-title":"Hematologic disorders associated with ischemic stroke","volume":"140","author":"Tatlisumak","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-9343(92)90576-W","article-title":"Cardiac involvement in patients with myeloproliferative disorders","volume":"93","author":"Reisner","year":"1992","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF01307724","article-title":"Adult \u201cidiopathic\u201d extrahepatic venous thrombosis. Importance of putative \u201clatent\u201d myeloproliferative disorders and comparison with cases with known etiology","author":"Cardin","year":"1992","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB21","first-page":"501","article-title":"Essential thrombocythemia in pregnancy","volume":"71","author":"Jones","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB23","first-page":"889","article-title":"Prognostic parameters in polycythaemia vera rubra. Correlations of clinical and histomorphological features in 60 patients","volume":"82","author":"Zankovich","year":"1987","journal-title":"Med Klin"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2141.1982.tb01900.x","article-title":"Uncontrolled thrombocytosis in chronic myeloproliferative disorders","volume":"50","author":"Kessler","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0025-6196(12)60486-8","article-title":"Essential thrombocythemia in young adults","volume":"66","author":"McIntyre","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB26","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","article-title":"Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients","volume":"67","author":"Colombi","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01707281","article-title":"Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients","volume":"63","author":"Wehmeier","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.33755","article-title":"Therapeutic options for essential thrombocythemia and polycythemia vera","volume":"29","author":"Solberg","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB30","first-page":"182","article-title":"Hemorheology in the erythrocytoses","volume":"68","author":"Pearson","year":"2001","journal-title":"Mt Sinai J Med"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB31","first-page":"421","article-title":"Myeloproliferative disorders\u2014Neurological complications","volume":"6","author":"Tarach","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W","article-title":"Thrombotic complications in essential thrombocythemia with relatively low platelet counts","volume":"56","author":"Regev","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB33","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood.V100.5.1596.h81702001596_1596_1601","article-title":"Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia","volume":"100","author":"Shih","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V100.2.714","article-title":"The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia","volume":"100","author":"Teofili","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.10153","article-title":"Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia","volume":"71","author":"Ruggeri","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB37","first-page":"796a","article-title":"High risk of deep vein thrombosis in carriers of the prothrombin gene mutation in patients with polycythemia vera and essential thrombocythemia","volume":"100","author":"Gisslinger","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB38","first-page":"590a","article-title":"Multiple inherited thrombophilic factors in essential thrombocythemia and polycythemia vera","volume":"100","author":"Cacciola","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/1096-8652(200010)65:2<136::AID-AJH8>3.0.CO;2-6","article-title":"High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders","volume":"65","author":"Faurschou","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.1999.01340.x","article-title":"Homocysteine levels in polycythaemia vera and essential thrombocythaemia","volume":"105","author":"Gisslinger","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ajh.10149","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome","volume":"71","author":"Li","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1365-2141.1999.01234.x","article-title":"Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with anagrelide","volume":"104","author":"Bellucci","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB43","first-page":"462","article-title":"Simultaneous study of platelets and phagocytes in myeloproliferative disorders","volume":"38","author":"Laharrague","year":"1984","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB44","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2141.1999.01399.x","article-title":"Thrombosis and bleeding in myeloproliferative disorders","volume":"105","author":"Manoharan","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.02.008_BIB45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x","article-title":"The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count","volume":"93","author":"van Genderen","year":"1996","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2004.02.008_BIB46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10428199609074364","article-title":"Acquired von Willebrand disease in myeloproliferative disorders","volume":"22","author":"van Genderen","year":"1996","journal-title":"Leuk Lymphoma"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:12:13Z","timestamp":1758521533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":46,"alternative-id":["S0037196304000368"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.02.008","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}